Category: CBSA News

This past week, the Biotechnology Innovation Organization (BIO) hosted its annual patient advocacy summit, the Patient Advocacy Changemakers Event (PACE), in Washington, D.C. The theme for this year’s...

By: Fitzsimons Innovation Community When Israel Villaseñor, Chief Strategy Officer of IMD Path, talks about his company's journey to Colorado, he uses a word that perfectly captures how it all happene...

For Immediate Release: October 30, 2025     NEWS RELEASE  Denver, Colorado – The University of Colorado Denver and the University of Colorado Anschutz, in partnership with Col...

On October 3, despite hearing testimony from a variety of stakeholders (including CBSA) expressing significant concerns, the Colorado Prescription Drug Affordability Board (PDAB or Board) set its firs...

NEWS RELEASE For Immediate Release: October 8, 2025 Enliven Therapeutics and Umoja Named Company of the Year FinalistsAmbrosia Biosciences, EnteroTrack, RheumaGen, and VitriVax Selected as Rising Star...

By: Fitzsimons Innovation Community As you know from all the buzz, this year marks a milestone for Fitzsimons Innovation Community—25 years since the opening of our first labs in Bioscience 1 in 2000....

As the federal government shuts down following the failure of Congress to agree on how to fund the government (with healthcare standing out as a flashpoint), and after the Trump Administration instruc...

This week’s policy blog includes federal and state updates on topics relevant to Colorado’s life sciences ecosystem:  Reauthorization of SBIR/STTR Programs  Colorado’s Budget Shortfall and S...

By: Elyse Blazevich Fitzsimons Innovation Community welcomed Elyse Blazevich as its guest blogger. As President & CEO of Colorado BioScience Association among many other roles, Elyse is at the for...

In recent weeks, CBSA’s Policy + Advocacy team has continued to strengthen our relationships with and showcase Colorado’s life sciences ecosystem to our state and federal legislators, legislative/cong...